AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
23
Employees23
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
23
Employees23

AIM Key Statistics

Market cap
7.34M
Market cap7.34M
Price-Earnings ratio
-0.11
Price-Earnings ratio-0.11
Dividend yield
Dividend yield
Average volume
79.39K
Average volume79.39K
High today
$2.88
High today$2.88
Low today
$2.59
Low today$2.59
Open price
$2.65
Open price$2.65
Volume
53.36K
Volume53.36K
52 Week high
$39.00
52 Week high$39.00
52 Week low
$2.33
52 Week low$2.33

AIM News

TipRanks 1d
AIM ImmunoTech releases CEO Corner segment

AIM ImmunoTech (AIM) announced the next CEO Corner segment has been published on the Company’s website. In this latest CEO Corner segment, AIM Chief Executive O...

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.